GSK Ends Acuitas’ Bid to Clear Covid Shot of Patent Allegations

A federal judge tossed Acuitas Therapeutics Inc.'s lawsuit seeking a declaration the Covid-19 vaccine Comirnaty doesn’t infringe patents that GSK Plc asserts in a separate case against Acuitas’ partners Pfizer Inc. and BioNTech SE.

Judge Gregory B. Williams granted a motion by GSK’s GlaxoSmithKline Biologicals SA and GlaxoSmithKline LLC units to dismiss Acuitas’ suit for lack of subject matter jurisdiction, according to an order issued Thursday in the US District Court for the District of Delaware. The judge gave the parties 21 days to submit a joint proposed redacted version of his sealed concurrent opinion explaining his reasoning.

Acuitas ...